FRG Family Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Hold |
3,351
| – | – | 0.19% | 79 |
|
|
2025
Q4 | $1.1M | Sell |
3,351
-170
| -5% | -$53.9K | 0.17% | 86 |
|
|
2025
Q3 | $994K | Sell |
3,521
-70
| -2% | -$20.3K | 0.16% | 90 |
|
|
2025
Q2 | $1M | Hold |
3,591
| – | – | 0.17% | 83 |
|
|
2025
Q1 | $1.12M | Hold |
3,591
| – | – | 0.22% | 76 |
|
|
2024
Q4 | $936K | Hold |
3,591
| – | – | 0.17% | 84 |
|
|
2024
Q3 | $1.16M | Hold |
3,591
| – | – | 0.21% | 74 |
|
|
2024
Q2 | $1.18M | Hold |
3,591
| – | – | 0.23% | 71 |
|
|
2024
Q1 | $984K | Hold |
3,591
| – | – | 0.19% | 77 |
|
|
2023
Q4 | $1.03M | Hold |
3,591
| – | – | 0.21% | 71 |
|
|
2023
Q3 | $965K | Sell |
3,591
-460
| -11% | -$115K | 0.22% | 74 |
|
|
2023
Q2 | $899K | Sell |
4,051
-670
| -14% | -$155K | 0.2% | 81 |
|
|
2023
Q1 | $1.14M | Sell |
4,721
-275
| -6% | -$67.5K | 0.26% | 67 |
|
|
2022
Q4 | $1.31M | Sell |
4,996
-85
| -2% | -$22.8K | 0.31% | 58 |
|
|
2022
Q3 | $1.15M | Sell |
5,081
-80
| -2% | -$19.4K | 0.28% | 61 |
|
|
2022
Q2 | $1.26M | Hold |
5,161
| – | – | 0.29% | 61 |
|
|
2022
Q1 | $1.25M | Hold |
5,161
| – | – | 0.24% | 64 |
|
|
2021
Q4 | $1.16M | Sell |
5,161
-46
| -0.9% | -$9.71K | 0.22% | 68 |
|
|
2021
Q3 | $1.11M | Buy |
5,207
+140
| +3% | +$32.2K | 0.22% | 66 |
|
|
2021
Q2 | $1.24M | Hold |
5,067
| – | – | 0.23% | 64 |
|
|
2021
Q1 | $1.26M | Sell |
5,067
-46
| -0.9% | -$11K | 0.26% | 62 |
|
|
2020
Q4 | $1.18M | Buy |
5,113
+435
| +9% | +$100K | 0.26% | 64 |
|
|
2020
Q3 | $1.19M | Buy |
4,678
+20
| +0.4% | +$4.96K | 0.29% | 59 |
|
|
2020
Q2 | $1.1M | Hold |
4,658
| – | – | 0.29% | 57 |
|
|
2020
Q1 | $944K | Buy |
4,658
+158
| +4% | +$34.5K | 0.29% | 60 |
|
|
2019
Q4 | $1.08M | Sell |
4,500
-235
| -5% | -$51.8K | 0.26% | 70 |
|
|
2019
Q3 | $916K | Sell |
4,735
-1,380
| -23% | -$265K | 0.24% | 80 |
|
|
2019
Q2 | $1.13M | Sell |
6,115
-1,465
| -19% | -$262K | 0.3% | 71 |
|
|
2019
Q1 | $1.44M | Sell |
7,580
-270
| -3% | -$51.6K | 0.41% | 63 |
|
|
2018
Q4 | $1.53M | Sell |
7,850
-250
| -3% | -$48.8K | 0.5% | 59 |
|
|
2018
Q3 | $1.68M | Sell |
8,100
-170
| -2% | -$33.5K | 0.46% | 61 |
|
|
2018
Q2 | $1.53M | Buy |
8,270
+60
| +0.7% | +$10.6K | 0.46% | 62 |
|
|
2018
Q1 | $1.4M | Buy |
8,210
+547
| +7% | +$100K | 0.46% | 68 |
|
|
2017
Q4 | $1.33M | Sell |
7,663
-712
| -9% | -$126K | 0.43% | 72 |
|
|
2017
Q3 | $1.56M | Sell |
8,375
-380
| -4% | -$67.3K | 0.54% | 61 |
|
|
2017
Q2 | $1.51M | Buy |
8,755
+910
| +12% | +$148K | 0.56% | 60 |
|
|
2017
Q1 | $1.29M | Buy |
7,845
+1,100
| +16% | +$183K | 0.5% | 65 |
|
|
2016
Q4 | $986K | Buy |
6,745
+1,515
| +29% | +$228K | 0.41% | 74 |
|
|
2016
Q3 | $872K | Buy |
5,230
+795
| +18% | +$134K | 0.39% | 77 |
|
|
2016
Q2 | $675K | Buy |
4,435
+455
| +11% | +$70.7K | 0.31% | 85 |
|
|
2016
Q1 | $595K | Buy |
3,980
+115
| +3% | +$17.1K | 0.29% | 85 |
|
|
2015
Q4 | $627K | Buy |
+3,865
| New | +$608K | 0.31% | 84 |
|
Other funds holding AMGN
VCM
VPM
FRG Family Wealth Advisors's AMGN Position: Q1 2026 in Review
FRG Family Wealth Advisors held its Amgen (AMGN) position steady in Q1 2026 at 3,351 shares worth $1.18M. The position accounts for 0.19% of the portfolio, ranked #79.
FRG Family Wealth Advisors first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.68M in Q3 2018. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- FRG Family Wealth Advisors held 3,351 shares of Amgen worth $1.18M as of Q1 2026.
- FRG Family Wealth Advisors left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.19% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #79 holding.
- FRG Family Wealth Advisors first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
- FRG Family Wealth Advisors's Amgen position peaked at $1.68M in Q3 2018.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.